For the renewal period, the previous Neuropsychology (NP) Core and memory Project will be combined within one unit, which will address common aims in a more efficient and integrated fashion. Based upon our findings so far, we have been able to devise a briefer test battery that includes the essential components of the standard clinical test battery as well s more experimental NP tests selected for their relevance to subcortical rain pathology. In the next 5 years we propose to focus on the longer term temporal and spatial (anatomic) progression of the NP deficits associated with HIV infection. Particularly, using our large cohort of dated seroconverters, we will chart the incidence and prevalence of both general and specific NP impairments at each year after infection. NP status and its changes will be related to potentially important host and viral factors, in addition to functional and structural brain imaging in life, and postmortem measures of regionally specific CNS viral burden and damage. Finally, we will further explore the everyday life significance of mild NP impairments in HIV+persons who are medically asymptomatic or minimally symptomatic; this will be done by comparing matched NP impaired and unimpaired subjects with respect to changes in employment status and performance on standardized work samples. In addition to testing specific hypotheses regarding the NP impairment associated with HIV infection, the new NP Core will continue to provide comprehensive neurobehavioral data for comparison with data from all other core study components and individual projects within the Center.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH045294-07
Application #
3737751
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Joseph, Jeymohan; Cinque, Paola; Colosi, Deborah et al. (2016) Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA. J Virus Erad 2:243-250
Bharti, Ajay R; Woods, Steven Paul; Ellis, Ronald J et al. (2016) Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning. HIV AIDS (Auckl) 8:93-9
Weinrich, James D; Klein, Fritz; McCutchan, J Allen et al. (2014) Cluster Analysis of the Klein Sexual Orientation Grid in Clinical and Nonclinical Samples: When Bisexuality Is Not Bisexuality. J Bisex 14:349-372
Wrasidlo, Wolf; Crews, Leslie A; Tsigelny, Igor F et al. (2014) Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders. Br J Pharmacol 171:5757-73
Klein, Fritz; Weinrich, James D (2014) Homogeneous Gynephiles and Heterogeneous Androphiles: A Factor Analysis of Differences and Similarities in Attractions to the Sexes as a Function of Sexual Orientation. J Bisex 14:468-501
Fields, Jerel; Dumaop, Wilmar; Rockenstein, Edward et al. (2013) Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer. J Neurovirol 19:89-101
Desplats, Paula; Dumaop, Wilmar; Smith, David et al. (2013) Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology 80:1415-23
Gelman, Benjamin B; Lisinicchia, Joshua G; Morgello, Susan et al. (2013) Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. J Acquir Immune Defic Syndr 62:487-95
Soontornniyomkij, Virawudh; Everall, Ian P; Moore, David J et al. (2012) Increased cortical expression of FK506 binding protein-51 in HIV-associated neurocognitive disorders. J Neurovirol 18:313-22
Soontornniyomkij, Virawudh; Moore, David J; Gouaux, Ben et al. (2012) Cerebral ?-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ?4 carriers. AIDS 26:2327-35

Showing the most recent 10 out of 98 publications